- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-9378
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antiviral therapy in acute viral hepatitis B: why and when ; volume:4 ; number:1 ; day:16 ; month:1 ; year:2009 ; pages:1-2 ; date:12.2009
Infectious agents and cancer ; 4, Heft 1 (16.1.2009), 1-2, 12.2009
- Creator
-
Morelli, Giuseppe
- Contributor
-
Perrella, Alessandro
Sbreglia, Costanza
Bellopede, Pasquale
Riccio, Vincenzo
Perrella, Oreste
SpringerLink (Online service)
- DOI
-
10.1186/1750-9378-4-2
- URN
-
urn:nbn:de:1111-2016072622352
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Morelli, Giuseppe
- Perrella, Alessandro
- Sbreglia, Costanza
- Bellopede, Pasquale
- Riccio, Vincenzo
- Perrella, Oreste
- SpringerLink (Online service)
Other Objects (12)
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies
Antiviral drugs against hepatitis C virus
SUMOylation in Viral Replication and Antiviral Defense
Viral recognition and the antiviral interferon response
TRIM5alpha contributes to the anti-viral state
Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy
Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies
Antiviral drugs against hepatitis C virus
SUMOylation in Viral Replication and Antiviral Defense
Viral recognition and the antiviral interferon response
TRIM5alpha contributes to the anti-viral state
Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy
Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies
Antiviral drugs against hepatitis C virus
SUMOylation in Viral Replication and Antiviral Defense
Viral recognition and the antiviral interferon response
TRIM5alpha contributes to the anti-viral state
Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy